Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities    
Net income (loss) $ 32,699 $ 27,628
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 11,452 9,527
Equity-based compensation 7,881 8,351
Equity method investments 2,381 (10,725)
Non-cash gain on securitization (22,349) (18,136)
Gain on sale of receivables and investments 0 1,547
Changes in receivables held-for-sale 4,110 0
Changes in accounts payable and accrued expenses 2,421 1,218
Other (8,800) 2,048
Net cash provided by (used in) operating activities 29,795 21,458
Cash flows from investing activities    
Equity method investments (3,756) (229,800)
Equity method distributions received 77,196 57,545
Proceeds from sales of equity method investments 12,433 6,044
Purchases of receivables (114,276) (86,637)
Principal collections from receivables 29,332 88,932
Proceeds from sales of receivables 0 79,175
Purchases of real estate (23,178) (142,952)
Purchases of investments (19,127) (15,119)
Principal collections from investments 3,750 1,175
Funding of escrow accounts (28,759) (30,999)
Withdrawal from escrow accounts 29,090 1,919
Other (736) (459)
Net cash provided by (used in) investing activities (38,031) (271,176)
Cash flows from financing activities    
Proceeds from credit facilities 158,938 277,612
Principal payments on credit facilities (2,784) (386,234)
Proceeds from issuance of non-recourse debt 51,934 428,653
Principal payments on non-recourse debt (108,747) (46,120)
Proceeds from issuance of convertible notes 0 150,000
Payments on deferred funding obligations (70,373) (104,225)
Net proceeds of common stock issuances 15,326 98,316
Payments of dividends and distributions (53,063) (50,628)
Other (4,232) (17,316)
Net cash provided by (used in) financing activities (13,001) 350,058
Increase (decrease) in cash, cash equivalents, and restricted cash (21,237) 100,340
Cash, cash equivalents, and restricted cash at beginning of period 118,177 59,144
Cash, cash equivalents, and restricted cash at end of period 96,940 159,484
Interest paid 50,880 32,929
Non-cash changes in deferred funding obligations (financing activity) 843 157,851
Non-cash changes in receivables and investments (investing activity) (248) (157,851)
Non-cash changes in residual assets (investing activity) $ (23,335) $ (18,136)